Opening book details…
About this Medicine article
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma by Dang, Nam H.; Ogura, Michinori; Castaigne, Sylvie; Fayad, Luis E.; Jerkeman, Mats; Radford, John; Pezzutto, Antonio; Bondarenko, Igor; Stewart, Douglas A.; Shnaidman, Michael; Sullivan, Sharon; Vandendries, Erik; Tobinai, Kensei; Ramchandren, Radhakrishnan; Hamlin, Paul A.; Giné, Eva; Ando, Kiyoshi is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Dang, Nam H.; Ogura, Michinori; Castaigne, Sylvie; Fayad, Luis E.; Jerkeman, Mats; Radford, John; Pezzutto, Antonio; Bondarenko, Igor; Stewart, Douglas A.; Shnaidman, Michael; Sullivan, Sharon; Vandendries, Erik; Tobinai, Kensei; Ramchandren, Radhakrishnan; Hamlin, Paul A.; Giné, Eva; Ando, Kiyoshi
- Publisher
- John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 0007-1048)
- Published
- 2017
- Field
- Medicine (Health Sciences)